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Background: Mcm10 protein is essential for initiation and elongation phases of replication. Human cells proteolyze
Mcm10 during mitosis, presumably to ensure a single round of replication. It has been proposed that anaphase
promoting complex ubiquitinates Mcm10 in late M and early G1 phases.
Results: In contrast to the previous work, we report that the degradation of Mcm10 is initiated at the onset of
mitosis. Immunoblotting and immunofluorescence assays display that Mcm10 levels are low in all phases of
mitosis. We report that Mcm10 degradation is not dependent on anaphase promoting complex. Further, the
proteolysis in M-phase can be independently mediated by non-overlapping regions of Mcm10, apparently
employing a redundant mechanism to ensure downregulation.
Conclusions: It is believed that the proteolysis of Mcm10 during mitosis is a vital mechanism to prevent aberrant
initiation of replication and the present study describes the regulation of Mcm10 during this phase of the cell-
cycle.
Background
DNA replication in eukaryotes begins with the assembly
of the pre-replicative complex comprising of replication
initiators, the origin recognition complex, Cdc6, Cdt1,
and the replicative helicase, Mcm2-7 complex [1].
Increase in the activity of cyclin dependent kinases and
loading of replication factor, Mcm10 marks the transi-
tion from G1 to S phase. These events promote the
loading of Cdc45, RPA and DNA polymerases at the
replication origins to initiate DNA synthesis. The essen-
tial requirement of Mcm10 in DNA replication initiation
and elongation has been exhibited across species [2-7].
Mutations in Mcm10 cause a decrease in initiation of
replication, slow progression of DNA synthesis and stal-
ling of replication forks during elongation [8]. Since
Mcm10 is essential for replication initiation and elonga-
tion, its activity is regulated in a cell-cycle manner to
ensure a single round of replication. S. cerevisiae
Mcm10 protein is present in all phases of the cell cycle
though its association with chromatin is regulated to
ensure replication licensing [3].
Human Mcm10 protein is known to decrease in the
early G1 phase [9]. The levels of MCM10 mRNA have
been evaluated as the cells pass from M-phase into G1
phase. Though the Mcm10 protein decreased, the levels
of MCM10 mRNA increased within the same time per-
iod. These results demonstrate that the decrease in the
Mcm10 activity during the G1 phase is not due to
decrease in transcription but because of protein turn-
over. In this communication, we report that proteolysis
of human Mcm10 protein initiates before the onset of
mitosis. In an immunoblot with anti-Mcm10 antibody,
we observed that the M-phase blocked cells have down-
regulated the Mcm10 protein. On the basis of single cell
immunofluorescence, we show that asynchronously
growing cells in different phases of mitosis have reduced
levels of Mcm10. Also, Mcm10 downregulation in M-
phase is independent of the APC recognition motifs: the
destruction and the KEN box. We demonstrate that
Mcm10 degradation is not dependent on anaphase pro-
moting complex or on its recognition motifs but rather
mediated by non-overlapping regions, apparently
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Cell-cycle proteolysis of Mcm10 initiates before the onset
of mitosis
Published reports indicate that the nocodazole blocked
cells retain Mcm10 protein which decreases in late M-
phase and starts increasing 6 h after release [9]. When
MG132 was added to nocodazole released cells, there was
an increase in Mcm10 levels suggesting that the degrada-
tion that was occurring during the late M-phase was
blocked by proteasome inhibitors. In another report by the
same group, a stable HeLa cell line which expressed green
fluorescent protein-tagged Mcm10 from a human cytome-
galovirus immediate early promoter was established and
authors observed that the GFP-Mcm10 protein was
detectable by immunofluorescence during mitosis [10].
We looked at the levels of Mcm10 and observed that they
were significantly reduced in nocodazole blocked U2OS
cells (Figure 1A). Mcm10 appeared after 4-6 hours of
release from nocodazole block. This is in contrast to the
results obtained by Hanaoka and coworkers, who observed
Mcm10 band by immunoblotting with anti-rabbit anti-
body, which was raised against 127-512 aa region of
Mcm10. Therefore, we wanted to rule out that the absence
of Mcm10 signal was due to limited immunoreactivity of
the antibody used by us. We have used a polyclonal rabbit
antibody, Ab (N), which is raised against the full-length
protein, but showed weak immunoreactivity against the C-
terminal protein [11]. However, similar results were
obtained with another polyclonal rabbit antibody, Ab (FL),
which shows immunoreactivity against all regions of
Mcm10 (Figure 1A). As reported previously, the specificity
of both these antibodies in immunoblotting assays have
been established by RNAi (Additional file 1 and file 2: Fig-
ure S1A and S5A) [11]. In order to rule out that the
decrease of Mcm10 is an artifact generated by nocodazole
toxicity, we blocked the cells with other reagents in M-
phase and assayed the stability of Mcm10. Vincristine
binds to tubulin dimers and inhibits the assembly of
microtubule structures, blocking cells in metaphase. Col-
chicine inhibits microtubule polymerization by binding to
tubulin and thereby blocks cells in metaphase. Taxol
hyper-stabilizes the beta subunit of tubulin, which is then
unable to disassemble inducing a cell-cycle block at the
metaphase/anaphase transition. U2OS cells blocked with
any of these drugs displayed low levels of Mcm10 (Figure
1C). On the basis of the above data, we conclude that
human cells have low levels of Mcm10 in mitosis.
As reported previously, we observed that the drop in
Mcm10 levels during mitosis is dependent on the pro-
teasome (Additional file 3: Figure S2B). To rule out that
loss of recognition of Mcm10 during mitosis could be
due to epitope masking, we established that the Mcm10
antibody recognizes the mitotic forms of Mcm10. Since
Mcm10 is naturally proteolyzed during mitosis we
expressed the HA-tagged NTD+ID domain which is
resistant to cell cycle-regulated degradation and tested
whether the anti-Mcm10 antibody (Ab [FL]) recognizes
this forms of Mcm10 during M-phase. U2OS cells
expressing the NTD+ID domain of Mcm10 were
blocked with nocodazole, released and harvested at reg-
ular intervals in order to collect cells in different phases
of the cell cycle (Figure 2A). As observed previously, an
anti-HA antibody immunoblot confirmed that the NTD
+ID domain of Mcm10 was resistant to degradation in
nocodazole blocked cells. An anti-Mcm10 antibody
immunoblot displayed that the levels of endogenous
Mcm10 levels were low in M phase and increased
around 8 h after nocodazole release but the NTD+ID
domain recognized through the same antibody did not
show a decrease in levels, displaying that the Mcm10
antibody recognizes the mitotic forms of Mcm10.
Single-cell imaging displays reduced levels of Mcm10
during mitosis
We also looked at Mcm10 levels in single cells as they
passed through interphase and various phases of mitosis.
HeLa cells were fixed and visualized for endogenous
Mcm10 using rabbit polyclonal anti-Mcm10 antibody,
Ab (N), in combination with an anti-rabbit TRITC sec-
ondary antibody while microtubules were visualized
with a mouse monoclonal antibody to alpha-tubulin
conjugated to FITC (Figure 3A). The specificity of the
antibody in immunofluorescence assays has been estab-
lished by RNAi (Additional file 1: Figure S1B). From the
asynchronously growing culture, we identified cells in
prophase, metaphase, anaphase and telophase, and
assayed for Mcm10 and alpha-tubulin localization (Fig-
ure 3A). We observed that the cells in prophase or pro-
metaphase, with condensed chromatin and bi-polar
centrosomes, were negative for Mcm10 signal (Figure
3 A ,t o pp a n e l ) .I nt h es a m ef i e l d s ,w ec o u l do b s e r v e
interphase cells that were positive for Mcm10 signal,
ruling out errors in our visualization method (arrows in
fields 1, 2 and 3 point to prophase cells while other cells
in same fields are in interphase). As previously reported,
not all interphase cells are positive for Mcm10 signal
a n dp r e s u m a b l yt h e s ea r et h ec e l l si ne a r l yG 1 phase.
Similarly, cells in metaphase, identified by the presence
of equatorial plate and polar microtubules, were also
negative for Mcm10 signal (Figure 3A, middle panel).
Cells in anaphase and telophase identified by segregated
sister chromatids and shortened kinetochore microtu-
bules, were also negative for Mcm10 signal (Figure 3A,
third and bottom panel). To confirm that the loss of
detection of Mcm10 is not due to the protein becoming
soluble during mitosis and that our immunofluorescence
protocol can detect soluble proteins during mitosis, we
have compared the levels of Mcm10 and cyclin B in
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Page 2 of 15nocodazole blocked cells. HeLa cells arrested in prome-
taphase (marked by arrowheads) were negative for
Mcm10 signal but retained the cyclin B signal, establish-
ing the accuracy of our immunofluorescence assay
(Additional file 3: Figure S2A). Therefore, our results
demonstrate that the levels of Mcm10 protein are signif-
icantly reduced during mitosis.
It is known that nocodazole interferes with the poly-
merization of microtubules and cells treated with noco-
dazole enter mitosis but cannot form metaphase
spindles thereby activating the spindle assembly
checkpoint which causes an arrest in prometaphase. As
explained earlier in Figure 1, HeLa cells were treated
with colchicine, nocodazole, taxol or vincristine for 15 h
to obtain cells arrested in prometaphase. Incubation
with any of these drugs resulted in disorganized micro-
tubules and condensed chromosomes, confirming a M-
phase block (Figure 3C). Prometaphase cells have been
marked by arrowheads and we observed that these cells
were negative for Mcm10 signal confirming that Mcm10
degradation has been initiated at this stage of mitosis.
We determined the levels of endogenous Mcm10 and
Figure 1 Endogenous Mcm10 levels are low during mitosis. U2OS cells were blocked at the mitotic phase with nocodazole for 16 h and
were either harvested immediately (0 h) or released in nocodazole-free medium and then harvested at the indicated time-points and used for
immunoblotting and flow cytometry. (A) Levels of endogenous Mcm10 were evaluated by Ab (N) and Ab (FL) antibody. ASN refers to samples
from asynchronously growing cells while NS points to a non-specific band that displays equal protein loading in different lanes. (B) Flow
cytometry of propidium iodide-stained DNA of U2OS cells, as described in (A), show an M phase block and release. The colored key denotes
cells obtained at different time-points. (C) and (D) U2OS cells were blocked in mitosis with 0.5 μg/ml colchicine, 0.10 μg/ml nocodazole, 0.3 μg/
ml taxol or 0.2 μg/ml vincristine for 16 h and analyzed for levels of Mcm10 (C) and DNA content (D) by immunoblotting and flow cytometry
respectively. The observed mobility of endogenous Mcm10 and cyclin B was 110 kDa and 55 kDa respectively.
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Page 3 of 15Figure 2 Cell cycle-regulated degradation of Mcm10 is not dependent on APC recognition motifs: KEN and destruction box. (A) Anti-
Mcm10 antibody recognizes the mitotic forms of Mcm10. U2OS cells expressing the NTD+ID domain of Mcm10 (fused to GFP and HA epitope
tags) were arrested in M-phase using nocodazole (0 h) and then harvested at the indicated time-points after release into drug-free medium. The
levels of the NTD+ID domain of Mcm10 were independently evaluated by anti-HA (bottom panel) and anti-Mcm10 (middle panel) antibody. The
same samples were probed with anti-Mcm10 antibody (Ab [N]) to display the levels of endogenous Mcm10 (top panel). ASN refers to samples
from asynchronously growing cells. The antibody used for immunoblotting and the protein detected by it have been listed on the left and right
sides of a particular western blot. The observed mobility of endogenous Mcm10 and NTD+ID domain (fused to GFP and HA epitope tags) was
110 kDa and 97 kDa respectively. (B) U2OS cells expressing HA-tagged full length Mcm10 were arrested in M-phase using nocodazole (0 h) and
then harvested at the indicated time-points after release into drug-free medium. The levels of endogenous Mcm10 and HA-tagged full length
Mcm10 were evaluated at different time points by anti-Mcm10 (top panel) and anti-HA (middle panel) antibody. NS points to a non-specific
band that displays equal protein loading. The observed mobility of HA-tagged FL Mcm10 was approximately 115 kDa. (C) U2OS cells expressing
wing-helix (WH) fragment of Mcm10 were arrested in M-phase using nocodazole (0 h) and then harvested at the indicated time-points after
release into drug-free medium. The levels of endogenous Mcm10, WH fragment and cyclin B were evaluated at different time points after
release from nocodazole. The observed mobility of WH fragment of Mcm10 (fused to GFP and HA epitope tags) was approximately 50 kDa. (D)
The flow cytometry of propidium iodide-stained DNA of stable cell-line expressing WH fragment has been shown. The colored key denotes cells
obtained at different time-points. (E) Immunofluorescence with HA antibody displays that the WH fragment of Mcm10 tagged with a nuclear
localization signal is directed to the nucleus.
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Page 4 of 15Figure 3 All phases of mitosis show low levels of endogenous Mcm10. (A) and (B) For evaluating subcellular localization of endogenous
proteins, HeLa cells were fixed in formaldehyde, permeabilized with Triton X-100 and DNA was stained with 4, 6-diamidino-2-phenylindole
(DAPI). To visualize Mcm10, immunofluorescence was performed using a rabbit polyclonal anti-Mcm10 antibody in combination with an anti-
rabbit TRITC secondary antibody while microtubules were visualized with a mouse monoclonal antibody to alpha-tubulin conjugated to FITC.
From unperturbed asynchronously growing culture, HeLa cells that are in prophase, metaphase, anaphase and telophase were identified and
have been marked by arrowheads in panel (A). The arrangement of immunofluorescence images obtained from a single field has been
illustrated in panel (B) and the bottom right square of each field is a merge of DAPI, FITC and TRITC images. Field numbers have been marked
at the top-right corner of each field. (C) To obtain cells arrested in prometaphase (shown by arrowheads), HeLa cells were treated with
colchicine, nocodazole, taxol or vincristine as described in Figure 1 and evaluated for Mcm10 levels by immunofluorescence.
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cells by immunofluorescence using a rabbit anti-Mcm10
antibody, Ab (N), and mouse anti-cyclin A antibody
respectively (Figure 4A). Utilizing the same antibodies,
we have demonstrated that the cyclin A levels begin to
increase in the S phase and it is degraded in the M-
phase (Additional file 4: Figure S3). We observed that
Mcm10 was present till the G2 phase as almost all the
cells (94%) that retained cyclin A signal also stained
positive for Mcm10 (Figure 4A). Combining the above
results, we establish that Mcm10 is present till the G2
phase and is degraded around the G2/M boundary.
Live-cell imaging demonstrates that Mcm10 is absent
during the M-phase
An alternate approach to address the levels of Mcm10
during mitosis would be to evaluate the cycling of
Mcm10 in live cells. Since it has been reported that
Mcm10 protein expression is not mainly regulated at
the transcriptional level, we expressed EGFP-tagged
Mcm10 from cytomegalovirus immediate early promoter
[9]. HeLa cells were transfected with pEGFP C3-Mcm10
and two days after transfection, we observed a 140 kDa
band with Mcm10 immunoblot, confirming the expres-
sion of EGFP-tagged Mcm10 (Additional file 5: Figure
S4A). HeLa cells transfected with blank pEGFP-C3 vec-
tor displayed cytoplasmic EGFP signal while EGFP
expressed in fusion with Mcm10 was guided to the
nucleus (Additional file 5: Figure S4B). We evaluated
the EGFP signal during mitosis, when the cells appear
rounded in phase-contrast microscope. We expressed
the EGFP-tagged full-length Mcm10 in 293 cells and
tracked the EGFP signal and cell division of 293 cells
Figure 4 Mcm10 is present in most cells that were positive for cyclin A. (A) A field of asynchronously growing HeLa cells visualized for
Mcm10 and cyclin A. Mcm10 was visualized by a rabbit anti-Mcm10 antibody in conjugation with anti-rabbit FITC antibody (third panel) while
cyclin A was visualized with mouse anti-cyclin A antibody in conjugation with anti-mouse Alexa 594 antibody (first panel). DNA was stained with
DAPI (second panel) while the right panel is a merge of images obtained from FITC, Alexa 594 and DAPI immunofluorescence. Cell 1 is positive
for FITC and negative for Alexa 594 signal while cell 2 is positive for Alexa 594 but negative for FITC signal and cell 3 is positive for both
demonstrating that there is no bleed-through of fluorescent signals. (B) RNAi confirms the cyclin A immunofluorescence signal while Mcm10
signal has been authenticated previously [11]. HeLa cells were transfected with GL2 or CYCLIN A siRNA oligos and later processed for
immunofluorescence with the mouse anti-cyclin A antibody. The scale bar is 20 microns.
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and as shown in Figure 5, we located a cell that is in
mitosis and undergoes cytokinesis after 1 h 40 min (the
two daughter cells have been marked by arrows). We
observed that the cell was negative for Mcm10 during
mitosis but the daughter cells accumulated Mcm10 after
8h ,d u r i n gt h eG 1 phase of the cell cycle. The overex-
pression of Mcm10 leads to a cell-cycle block during
Figure 5 Time-lapse imaging analysis of asynchronous culture of 293 cells expressing EGFP-Mcm10. 293 cells were transfected with
pEGFPC3-Mcm10 and 24 h after transfection, cells were placed on a live cell imaging stage (37°C with 5% CO2), and images were captured at
20 min intervals with a 10× objective of a Zeiss Observer Z1 inverted fluorescent microscope using an AxioCam HRm digital CCD camera. Some
of the representative images have been shown along with the time elapsed since the start of imaging. Top rows are phase-contrast images
while the bottom rows are corresponding EGFP fluorescent images in dark field. The two arrows indicate the daughter cells after cytokinesis at
1 h 40 min.
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G2 to M could not be observed.
We have reported that the 61 aa ZF motif (783-843aa)
of Mcm10 is sufficient for M phase proteolysis and
therefore we expressed EGFP-tagged ZF motif of
Mcm10 and tracked the EGFP signal and cell division of
HeLa cells by fluorescence and phase-contrast micro-
scopy respectively as the cells progressed through mito-
sis. As shown in Figure S4C (Additional file 5), we
located a mitotic cell that undergoes cytokines after 1 h
20 min (the two daughter cells have been marked by
arrows). We observed that the cell was negative for
Mcm10 during mitosis but the daughter cells accumu-
lated Mcm10 after around 5 h. Therefore, utilizing a dif-
ferent cell-line, we establish that the full-length Mcm10
is low during mitosis. Summing up, using this antibody-
independent approach, we demonstrated that the
Mcm10 levels are low during mitosis.
APC is not required for cell cycle degradation of Mcm10
APC/C or cyclosome is a complex of many proteins that
functions as an E3 ubiquitin ligase during mitosis. Since
Mcm10 is low in the M-phase, there is a distinct possi-
bility that APC is involved in degradation of Mcm10.
Notably, Mcm10 contains destruction box sequence
(REQLAYLES) and a KEN box, motifs that are required
for recognition of substrates by APC [12]. To test
whether APC mediates the M-phase degradation of
Mcm10, we silenced APC3 subunit of APC, which
would effectively debilitate its ubiquitination ability.
HeLa cells transfected with APC3 siRNA for three con-
secutive days were blocked in the M-phase with nocoda-
zole for 15 h and subsequently released into nocodazole
free medium. RNAi against APC3 decreased the target
p r o t e i na n dm R N Ab u tt h a td i dn o ti n c r e a s et h el e v e l s
of Mcm10 in nocodazole blocked cells (Figure 6). RNAi
effectively inhibited the APC activity as evidenced by
increase in the levels of cyclin B (compare lanes 3 with
6 in Figure 6A). This strongly suggests that APC is not
involved in the cell-cycle degradation of Mcm10. We
have assayed the Mcm10 levels in asynchronous popula-
tions of cells transfected with APC3, CUL1, CDH1,
CDC20, BETA-TRCP and FBXW7 or control GL2
siRNA and observed that only minor variations were
observed in Mcm10 levels (Additional file 2: Figure S5).
We have previously reported that UV-irradiation specifi-
cally proteolyses Mcm10 and we have identified the E3
ubiquitin ligase mediates the UV-triggered and M-phase
proteolysis of Mcm10 [11].
APC recognition motifs are not required for cell cycle
degradation of Mcm10
We have previously utilized stable U2OS cells expres-
sing HA-tagged Mcm10 (utilizing the pMX-retroviral
vector that is based on the moloney murine leukemia
virus) to determine the segments of Mcm10 that are
essential for cell cycle-regulated degradation [11]. Full-
length Mcm10 can be broadly divided into N-terminal
(NTD), inner (ID), linker (LNK) and C-terminal (CTD)
domains (Figure 7). A coiled-coil motif is present within
the N-terminus of Mcm10, which is required for homo-
dimerization. The inner and C-terminal domains, which
contain zinc finger (ZF) and winged helix (WH) motifs,
bind to single- and double-stranded DNA, and the p180
subunit of DNA polymerase-alpha [13,14]. As reported
previously, we observed that the HA-tagged full length
Mcm10 protein behaves like the endogenous protein
[11]. U2OS cells expressing HA-tagged full length
Mcm10 were blocked with nocodazole, released and
harvested at regular intervals in order to collect cells in
different phases of the cell cycle. Endogenous Mcm10
levels were low in M phase and increased around 8 h
after release from nocodazole block (Figure 2B). HA-
tagged full-length Mcm10 showed a degradation pattern
similar to that of the endogenous protein, which
demonstrates that our assay for evaluating the degrada-
tion of different regions of Mcm10 is accurate.
We observed that the NTD+ID domain of Mcm10,
which contains the KEN box, was resistant to cell cycle-
regulated degradation. In the present study, we tested
whether the WH motif, that contains the destruction
box, is proteolyzed during the M-phase. Stable U2OS
cells expressing WH motif of Mcm10 (707-770 aa) was
blocked with nocodazole, which arrested the cells in M-
phase. The obtained mitotic cells were released from the
block and harvested at regular intervals in order to col-
lect cells in different phases of the cell cycle. The flow
cytometry profile of propidium iodide-stained DNA and
the levels of cyclin B demonstrate a block in M-phase
and subsequent progression through the cell cycle (Fig-
ure 2D). As noted previously, Mcm10 was absent in
nocodazole-released cells, demonstrating the natural
proteolysis of Mcm10 in M phase which began to
increase after 8 h, displaying the natural cycling of
Mcm10 levels (Figure 2C). Full-length Mcm10 expressed
from the retroviral vector showed a degradation pattern
similar to that of the endogenous protein, validating our
assay for evaluating the cell cycle-regulated degradation
of Mcm10. We observed that the WH motif fragment
was resistant to cell cycle-regulated degradation. We
confirmed that the nuclear localization signal expressed
in fusion with the WH motif steered it to the nucleus
and therefore change in cellular localization is not the
reason for resistance to proteolysis (Figure 2E). We have
previously reported that the LNK domain which does
not have either the KEN box or destruction box is pro-
teolyzed as cells pass through M-phase. Therefore, we
conclude that the KEN and destruction box of Mcm10
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proteolysis.
Mcm10 proteolysis utilizes independent non-overlapping
signals
To identify the domains required for Mcm10 proteolysis
during M-phase, we expressed different regions of
Mcm10 and assayed their stability. As noted previously,
the NTD+ID domain was resistant to cell cycle-regu-
lated degradation, but the LNK and CTD domains were
proteolyzed in M phase (Figure 8A). Though the ZF
motif was sufficient for M phase proteolysis of Mcm10,
the CTD domain lacking the ZF motif was also
degraded in M phase, signifying that though ZF motif is
sufficient, it is not essential for M phase proteolysis of
Mcm10 (Figure 9A). We now wanted to identify the
degron that is essential for degradation.
We further divided the CTD (607-875 aa) into three
fragments 607-707 aa, 707-770 aa (WH motif) and 770-
875 aa. We observed that the 607-707 aa and 707-770
aa fragment were resistant to proteolysis (Figure 8A,
panel 1 and results of WH motif in Figure 2C). How-
ever, the 770-875 aa fragment decreased in M-phase,
demonstrating that the signal for degradation lies in this
fragment. In order to identify the minimum sequence
required for Mcm10 degradation, we further divided the
770-875 aa fragment into three parts: 770-783 aa, 783-
843 aa and 843-875 aa. 770-783 aa fragment was par-
tially stable indicating that there could be an incomplete
degron in this fragment (Figure 8A, panel 3). The 783-
843 aa (ZF motif) and 843-875 aa decreased in M-phase
demonstrating that there are non-overlapping regions
that are sufficient for Mcm10 proteolysis (Figure 8A,
panel 4 and results of ZF motif in [11]). The ZF motif
was divided into 3 segments each of 20 amino acids:
783-803 aa, 803-823 aa and 823-843 aa. We observed
that 783-803 aa region was essential and sufficient for
degradation while 803-823 aa and 823-843 aa were not
proteolyzed (Figure 8C and 8E). Therefore, we have nar-
rowed to two regions that contain the degron: a 20 aa
region (783-803 aa) within the ZF motif and C-terminal
end of Mcm10 (843-875 aa).
Another independent region that is sufficient for
Mcm10 downregulation is the linker domain (440-607
aa). We divided the linker domain into three parts: 440-
471 aa, 471-525 aa and 525-607 aa. We observed that
though the linker domain is decreased during M-phase,
none of the three constituent fragments were proteo-
lyzed (Figure 9A). However, when we combined the
440-471 aa and 471-525 aa fragments, the degradation
ability was restored (Figure 9C, panel 1). Combining
440-471 aa with 525-607 aa or combing 471-525 aa with
525-607 aa did not result in M-phase degradation (Fig-
ure 9C, panel 2 and 3). Therefore, the degron in the lin-
ker domain lies within the stretch of 440-525 aa. Hence,
it seems that Mcm10 degradation is mediated by non-
overlapping regions, apparently to ensure downregula-
tion of Mcm10 even if proteolysis at any one region is
somehow blocked. There is no apparent sequence simi-
larity between the three minimal regions that are com-
petent for M-phase proteolysis: 440-525 aa, 783-803 aa
and 843-875 aa. This would suggest that the ubiquitina-
tion machinery is adaptable to recognize multiple
sequences to ensure Mcm10 proteolysis. Recognition of
Figure 6 Cell cycle degradation of Mcm10 is independent of APC. (A) HeLa cells were transfected on three consecutive days with APC3 or
control GL2 siRNA. After the third transfection, the cells were arrested with nocodazole for 15 h and were harvested after release from
nocodazole (Noc) for analysis of Mcm10 protein, along with asynchronous cells (ASN). Samples were also taken 2 h after release from
nocodazole (2 h) (B) The decrease of APC3 protein after RNAi was confirmed by immunoblotting with anti-APC3 antibody. NS points to a non-
specific band that displays equal protein loading in different lanes. (C) The decrease of APC3 mRNA was confirmed by RT-PCR and the numbers
indicate the relative intensity of the mRNA. (D) Flow cytometry of propidium iodide-stained DNA of HeLa cells, as described in (A) confirms a M-
phase block and release after siRNA depletion. The observed mobility of endogenous APC3 was 73 kDa.
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Page 9 of 15Figure 7 Schematic representation of Mcm10 and the fragments cloned into the pMX-puro vector. NTD, ID, LNK and CTD refer to N-
terminal, inner, linker and C-terminal domains. OB, ZF and WH refer to oligonucleotide binding, zinc finger and winged helix motifs, respectively.
The locations of Mcm10 fragments and the proteolysis during M-phase have been summarized based on the results obtained from Figure 8 and
9. Previously published results have been marked with ‘]’.
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Page 10 of 15Figure 8 Independent non-overlapping regions are sufficient for Mcm10 proteolysis during M-phase. U2OS cells expressing different
regions of Mcm10 were arrested in M-phase using nocodazole (0 h) and then harvested at the indicated time-points after release into drug-free
medium. The proteolysis of different regions of Mcm10 evaluated after release from nocodazole by immunoblotting with an anti-HA antibody
has been shown in parts (A), (C) and (E) and the flow cytometry of propidium iodide-stained DNA of stable cell-line expressing the
corresponding fragment has been shown in parts (B), (D) and (F) respectively. ASN refers to samples from asynchronously growing cells while NS
points to a non-specific band that displays equal protein loading. The observed mobility of fragments of Mcm10 (fused to GFP and HA epitope
tags) was as follows: 607-707: 52 kDa; 770-875: 52 kDa; 770-783: 42 kDa; 843-875: 42 kDa; 783-823: 44 kDa; 803-843: 44 kDa; 783-803: 40 kDa; 803-
823: 44 kDa; 823-843: 43 kDa.
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Page 11 of 15Figure 9 Residues 440-525 within the Linker domain are required for Mcm10 proteolysis during M-phase. U2OS cells expressing
different regions of Mcm10 were arrested in M-phase using nocodazole (0 h) and then harvested at the indicated time-points after release into
drug-free medium. The proteolysis of different regions of Mcm10 evaluated after release from nocodazole by immunoblotting with an anti-HA
antibody has been shown in parts (A) and (C) and the flow cytometry of propidium iodide-stained DNA of stable cell-line expressing the
corresponding fragment has been shown in parts (B) and (D) respectively. ASN refers to samples from asynchronously growing cells while NS
points to a non-specific band that displays equal protein loading. The observed mobility of fragments of Mcm10 (fused to GFP and HA epitope
tags) was as follows: LNK domain (440-607): 55 kDa; 440-471: 44 kDa; 471-525: 46 kDa; 525-607: 49 kDa; 440-525: 50 kDa; 471-607: 53 kDa; 440-
607 (471-525): 53 kDa.
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tures rather than primary sequence and that possibility
cannot be ruled for recognition of different domains of
Mcm10.
Discussion and Conclusions
We have observed that the Mcm10 levels are significantly
reduced in nocodazole blocked cells. This is in contrast
to the previous report where on the basis of estimation of
Mcm10 levels in asynchronous and nocodazole released
cells by immunoblots, the authors inferred that Mcm10
degradation begins after metaphase [9]. It is possible that
the Mcm10 protein observed after nocodazole treatment
was contributed by cells trapped at G2/M boundary. The
stabilization of Mcm10 by MG132 in nocodazole released
cells observed by them is likely due to non-degradation of
Mcm10 in these cells. It has been suggested that a
destruction box sequence (719-727 aa) could be recog-
nized by the anaphase-promoting complex for ubiquiti-
nation. Additionally, Mcm10 also contains a KEN box
sequence (71-73 aa) that is present in targets ubiquiti-
nated by APC. However, the NTD domain, which con-
tains the KEN box is not degraded during M-phase [11].
Similarly, the WH motif which contains the destruction
box is stable during mitosis (Figure 2C). However, the
linker region and ZF motif, which do not have either
destruction or KEN box, are proteolyzed during
M - p h a s e .I ns u m m a t i o n ,t h ea b o v ed a t aw o u l ds u g g e s t
that the APC recognition motifs are not required for
M-phase degradation of Mcm10. In this study, we have
also demonstrated that inhibition of APC does not block
cell-cycle degradation of Mcm10.
This study has discovered at least three independent
regions of Mcm10 that are sufficient for proteolysis dur-
ing M phase. Since the non-overlapping regions of
Mcm10 sufficient for M-phase proteolysis did not dis-
play sequence similarity, it suggests of a limited degen-
eracy of the E3 ligase to allow for recognition of
multiple substrates. CRL4 is known to mediate the ubi-
quitination of almost two dozen substrates, including
Cdt1, PCNA and histones that do not share sequence
similarity [15]. It is widely believed that the proteolysis
of Mcm10 during mitosis is a mechanism to prevent
aberrant initiation of replication and therefore it is pos-
sible that utilization of independent regions is a means
to ensure downregulation of Mcm10 even if proteolysis
at any one region is somehow blocked. The cloning of
stable mutants of full length Mcm10 would help us eval-
uate the effect of stable Mcm10 on cell-cycle progres-
sion and genomic stability. It is believed that the
proteolysis of Mcm10 during mitosis is a vital mechan-
ism to prevent aberrant initiation of replication and the
present study describes the regulation of Mcm10 during
this phase of the cell-cycle.
Methods
Cell culture, chemicals, antibodies, cell synchronization
and FACS analysis
Cell lines were maintained in DMEM supplemented with
fetal bovine serum and antibiotics. Specific chemicals and
antibodies used in this study are mentioned in the sup-
plementary methods (Additional file 6). HeLa cells were
transfected with specific siRNA oligos consecutively for
three days and were blocked with 40 ng/ml nocodazole
for 15 h. Later, cells were released in drug-free medium
and cells arrested in the M-phase were collected by
‘mitotic-shake off’. The obtained mitotic cells were then
re-plated in drug-free medium and harvested till 12 h to
collect cells in different phases of the cell cycle. HeLa
and U2OS cells were incubated with 40 ng/ml or 0.10
μg/ml nocodazole, 0.05 μg/ml or 0.2 μg/ml vincristine,
0.15 μg/ml or 0.5 μg/ml colchicine or 0.1 μg/ml or 0.3
μg/ml taxol for 15 h or 16 h respectively to obtain mitotic
cells. For cell cycle analysis, the cells were fixed with 70%
ethanol after washing with 1× PBS. Subsequently, the cell
pellet was resuspended in 1× PBS with 0.1% Triton X-
100, 20 μg/ml RNase and 70 μg/ml propidium iodide and
the flow cytometry was performed.The flow cytometry
data was acquired on Becton Dickinson FACS Calibur
machine by Cell Quest Pro software. Cell cycle analysis
was done by Dean/Jett/Fox method of FlowJo software.
Antibodies for immunoblotting and immunofluorescence
Anti-human Mcm10 antibody was produced using
recombinant His-tagged Mcm10 (cloned in pET28a vec-
tor), purified on nickel-NTA column (Qiagen). Rabbits
were injected with recombinant protein along with com-
plete Freund’s adjuvant to obtain Mcm10 Ab (N) and
Ab (FL). Anti-Mcm10 sera was affinity-purified using
Mcm10 conjugated sepharose column. Rabbit polyclonal
anti-cyclin B1 (Cat. No. Sc-752) was purchased from
Santa Cruz Biotechnology Mouse monoclonal anti-
APC3 (Cat. No. ab10538) and anti-alpha tubulin-FITC
(Cat. No. ab64503) were purchased from Abcam.Mouse
monoclonal anti-cyclin A (Cat. No. CS-4656) was
obtained from Cell Signaling Technology.Mouse mono-
clonal anti-HA (Cat.No. H3663) was obtained from
Sigma. Polyclonal goat anti-rabbit HRP (Cat.No. P0448),
polyclonal rabbit anti-mouse HRP (Cat.No. P0161) and
polyclonal swine anti-rabbit TRITC (Cat No.R0156)
were obtained from Dako. Alexa Fluor 488 goat anti-
rabbit IgG (Cat.No. A11008) and Alexa Fluor 594 goat
anti-mouse IgG (Cat.No. A110050) were obtained from
Molecular Probes, Invitrogen. For western blotting, cells
were harvested in 1× SDS sample buffer. Equal amount
of protein was separated on SDS-polyacrylamide gels
and then transferred onto nitrocellulose membranes.
Finally the results were assayed using the Enhanced
Chemiluminescence method.
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Page 13 of 15RNAi silencing and reverse-transcriptase PCR
Silencing of genes was done by transfecting specific 40-
80 nM siRNA duplex on three consecutive days and
cells were harvested 24 h post the last transfection.The
levels of protein and mRNA were evaluated by immuno-
blotting and reverse-transcriptase PCR respectively. For
reverse-transcriptase PCR, RNA was extracted using
TRIzol method and 0.25-1 μg RNA was used for cDNA
synthesis. The primers used for PCR are described in
the supplementary methods (Additional file 6)
Plasmid construction, transfection, immunoblotting and
immunofluorescence
Full-length Mcm10 was subcloned into BglII and SalI
sites of pEGFP-C3 vector, which carries the GFP
sequence at the N-terminal of the vector. Similarly,
Mcm10 cDNA was digested with either BglII and EcoRI
or BglII and MfeI and cloned in BamHI and EcoRI sites
of pMX-puro-NLS-HA vector. The sequences of the
cloning primers are provided in the supplementary
methods (Additional file 6). Stable U2OS cells expres-
sing Mcm10 and its fragments were generated as
described previously [11]. Cells of almost equal con-
fluency were lysed in proportionate volumes of Laemmli
buffer for immunoblotting. To demonstrate equal pro-
tein loading in each lane, immunoblotting was per-
formed and a nonspecific protein band was displayed.
For indirect immunofluorescence studies, HeLa cells
grown on glass coverslips in DMEM supplemented with
10% fetal bovine serum (FBS) were fixed with 4% for-
maldehyde in PBS for 10 min and then permeabilized
with 0.2% Triton X-100 in PBS for 5 min. Later, the
cells were blocked with 10% FBS in PBS with 0.1%
Tween-20. The cells were then stained with primary
antibody (1:100 or 1:500 dilution) for an hour followed
by either fluorescein isothiocyanate, Alexa-488 or Alexa-
594-conjugated anti-rabbit or anti-mouse antibody
(1:500 dilution) at room temperature. The coverslips
were then mounted with a mounting reagent with DAPI
and viewed under the Nikon TE2000-S inverted fluores-
cence microscope. Images were captured on Evolution
VF (Media Cybernetics) 12-bit color digital camera
using the ‘Q capture Pro’ software and contrast
enhancements were identically done for all the images
of a particular antibody/protein in an experiment. Some
images were captured using the Zeiss LSM 510 confocal
microscope and viewed using the Zeiss LSM Image
Browser Version 4,2,0,121 software.
Additional material
Additional file 1: Figure S1: RNA interference authenticates the
Mcm10 protein in immunoblotting and immunofluorescence assays.
(A, B) HeLa cells were transfected with GL2 or MCM10 siRNA and
subsequently processed for immunoblotting with anti-Mcm10 antibodies
(Ab [N] and Ab [FL]) or immunofluorescence with anti-Mcm10 antibody
(Ab [N]). NS points to a non-specific band that displays equal protein
loading.
Additional file 2: Figure S5: RNA interference authenticates the
Mcm10 protein in immunoblotting assays. (A) HeLa cells were
transfected with GL2 or MCM10 siRNA and subsequently processed for
immunoblotting with anti-Mcm10 antibodies (Ab [N] and Ab [FL]) to
display the whole gel. The black and shaded arrow head points to the
Mcm10 and a cross-reactive band respectively while NS refers to a non-
specific band that displays equal protein loading. (B) Mcm10 levels after
depletion of APC3, Cul1, Cdh1 and Cdc20. HeLa cells were transfected on
three consecutive days with APC3, CUL1, CDH1, CDC20 or control GL2
siRNA and after the third transfection, asynchronous cells (ASN) were
harvested for analysis of Mcm10 protein. NS points to a non-specific
band that displays equal protein loading. (C) Mcm10 levels after
depletion of beta-TRCP and FBXW7. HeLa cells were transfected on three
consecutive days with BETA-TRCP, FBXW7 or control GL2 siRNA. After the
third transfection, the cells were arrested with nocodazole for 15 h and
were harvested after release from nocodazole (Noc) for analysis of
Mcm10 protein, along with asynchronous cells (ASN). (D) The decrease of
BETA-TRCP and FBXW7 mRNA was confirmed by RT-PCR. The numbers
indicate the relative intensity of specific mRNA.
Additional file 3: Figure S2: Cyclin B is detectable in nocodazole
blocked cells. (A) Nocodazole blocked HeLa cells were visualized for
Mcm10 and cyclin B. Mcm10 was visualized by anti-Mcm10 antibody in
conjugation with anti-rabbit Alexa 488 antibody (top-right panel) while
cyclin B was visualized with anti-cyclin B antibody in conjugation with
anti-rabbit Alexa 488 antibody (bottom-right panel). DNA was stained
with DAPI (left panel). HeLa cells that are blocked in mitosis have been
marked by arrowheads. (B) HeLa cells were harvested after release from
(Noc) and treated with MG132 as indicated and immunoblotted with
anti-Mcm10 antibody (top panel). ASN refers to samples from
asynchronously growing cells not treated with nocodazole while NS
points to a non-specific band that displays equal protein loading. U2OS
cells expressing HA-tagged full length Mcm10 (second panel) or HA-
tagged linker domain of Mcm10 (third panel) were treated similarly.
Since MG132 interfered with the nocodazole block in U2OS cells, the
total population of cells after treatment with nocodazole and MG132
was loaded in second and third panel. The observed mobility of the
linker domain of Mcm10 (fused to GFP and HA epitope tags) was
approximately 55 kDa.
Additional file 4: Figure S3: Immunoblotting and
immunofluorescence assays demonstrate decrease in cyclin A
protein as cells enter mitosis. (A) HeLa cells were synchronized at G1/S
transition with hydroxyurea and later released and samples were
collected at 4 h intervals and processed for immunoblotting and
immunofluorescence. Cyclin A was visualized with mouse anti-cyclin A
antibody in conjugation with anti-mouse Alexa 594 antibody (right
panel) while DNA was stained with DAPI (left panel). Representative
fields of different time points have been shown. Note that Alexa 594
emission is visible as a red color after passing through the emission filter
of Nikon TE2000-S inverted fluorescence microscope. (B) Levels of
endogenous cyclin A and Mcm10 were evaluated by specific antibody.
ASN refers to samples from asynchronously growing cells while NS
points to a non-specific band that displays equal protein loading in
different lanes. (C) Flow cytometry of propidium iodide-stained DNA of
HeLa cells, as described in (A), shows a G1/S block and release. The
colored key denotes cells obtained at different time-points and the FACS
histogram shows peaks corresponding to different phases of the cell
cycle.
Additional file 5: Figure S4: Expression of GFP signal in HeLa cells
transfected with either pEGFPC3 or pEGFPC3-Mcm10. (A) Transfected
HeLa cells were harvested and analyzed by rabbit anti-Mcm10 antibody
which identifies the mobility of the endogenous Mcm10 (shaded
arrowhead) and exogenously expressed EGFP-Mcm10 (black arrowhead).
(B) Two days after transfection, cells were placed on a live cell imaging
stage (37°C with 5% CO2), and images were captured with a 40×
objective of a Zeiss Observer Z1 inverted fluorescent microscope using
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Page 14 of 15an AxioCam HRm digital CCD camera. (C) Time-lapse imaging analysis of
asynchronous culture of HeLa cells expressing EGFP-Mcm10. HeLa cells
were transfected with pEGFPC3-ZF Mcm10 and 24 h after transfection,
cells were placed on a live cell imaging stage (37°C with 5% CO2), and
images were captured at 20 min intervals as described in Figure 4. Some
of the representative images have been shown along with the time
elapsed since the start of imaging. Top rows are phase-contrast images
while the bottom rows are corresponding EGFP fluorescent images in
dark field. The two arrows indicate the daughter cells after cytokinesis at
1 h 20 min.
Additional file 6: Supplementary Methods.
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